What one share of Vistagen Therapeutics holds
We are a late clinical-stage therapeutics company focused on developing and potentially commercializing new medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia.
Vistagen Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.06 |
|---|---|
| Profit | −$1.66 |
| Cash and investments | $0.38 |
| Debt | $0.00 |
| Book value | $0.55 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $54.65 | −$497.11 | — | — | — | −$183.03 |
| 2013 | $6.64 | −$764.72 | — | — | — | −$362.78 |
| 2014 | — | −$114.28 | — | — | — | −$326.97 |
| 2015 | — | −$318.26 | — | — | — | −$399.81 |
| 2016 | $0.00 | −$872.52 | $0.45 | −$82.04 | — | −$35.91 |
| 2017 | $4.98 | −$46.30 | $0.95 | −$29.88 | — | $1.99 |
| 2018 | $0.00 | −$33.64 | $0.00 | −$19.57 | — | $9.01 |
| 2019 | — | −$27.02 | $0.18 | −$15.44 | — | $4.98 |
| 2020 | $0.00 | −$15.07 | $0.00 | −$10.78 | — | −$3.08 |
| 2021 | $0.38 | −$14.74 | $0.10 | −$4.30 | — | — |
| 2022 | $0.17 | −$7.38 | $0.03 | −$6.89 | — | $9.40 |
| 2023 | — | −$8.51 | $0.08 | −$7.22 | — | $1.65 |
| 2024 | $0.06 | −$1.52 | $0.00 | −$1.33 | — | $4.23 |
| 2025 | $0.02 | −$1.67 | — | — | — | $2.43 |
| 2026 | $0.03 | −$1.83 | — | — | — | $0.90 |
Common questions about Vistagen Therapeutics
How much does one share of Vistagen Therapeutics earn?
Over the last 12 months, Vistagen Therapeutics lost $1.66 for each share on $0.06 of sales.
Does Vistagen Therapeutics pay a dividend?
Vistagen Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Vistagen Therapeutics’s book value per share?
Vistagen Therapeutics’s book value is $0.55 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Vistagen Therapeutics have?
Each share of Vistagen Therapeutics has $0.38 of cash and investments and $0.00 of debt, as of June 30, 2026.
Has Vistagen Therapeutics bought back shares?
Vistagen Therapeutics’s share count rose about 154917% from 2012 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.